GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,000 | +30.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | -37.5% | 200 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $16,000 | +77.8% | 200 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $9,000 | -18.2% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | 0.0% | 200 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $11,000 | +37.5% | 200 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $8,000 | -46.7% | 200 | -50.0% | 0.00% | -50.0% |
| Q3 2018 | $15,000 | -53.1% | 400 | -42.9% | 0.00% | -50.0% |
| Q2 2018 | $32,000 | +220.0% | 700 | +250.0% | 0.01% | +166.7% |
| Q1 2018 | $10,000 | -64.3% | 200 | -71.4% | 0.00% | -62.5% |
| Q4 2017 | $28,000 | +21.7% | 700 | -8.5% | 0.01% | +14.3% |
| Q3 2017 | $23,000 | +155.6% | 765 | +131.8% | 0.01% | +133.3% |
| Q2 2017 | $9,000 | -25.0% | 330 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $12,000 | – | 330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |